Alvespimycin is identified as a novel therapeutic agent for diabetic kidney disease by chemical screening targeting extracellular vesicles by Daisuke Fujimoto, Shuro Umemoto, Teruhiko Mizumoto, Tomoko Kanki, Yusuke Hata, Yoshihiko Nishiguchi, Ryosuke Date, Jingxuan Zhang, Yutaka Kakizoe, Yuichiro Izumi, Masataka Adachi, Hirotatsu Kojima, Hideki Yokoi, Masashi Mukoyama, Takashige Kuwabara

Get full text